Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro evaluation of BAY Y3118, a new full-spectrum fluoroquinolone.

Chemotherapy - 1 Jan 1992

Bremm K D, Petersen U, Metzger K G, Endermann R

Abstract excerpt

BAY Y3118, 1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8- chloro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride, is a new fluoroquinolone with antibacterial activity against an expanded spectrum of species including Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Enterococcus faecium, Streptococcus pneumoniae, Streptococcus pyogenes, and also anaerobes such as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Infective Agents
Share to Drug Resistance, Microbial
Share to Enterobacteriaceae

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Fluoroquinolones

Share to Microbial Sensitivity Tests

Share to Mutation

Share to Quinolones

Share to Time Factors

Source

Identifiers

PMID: 1288961
DOI: 10.1159/000239031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro evaluation of BAY Y3118, a new full-spectrum fluoroquinolone.PMID 1288961Read ↗

Activity of Bay y3118 against quinolone-susceptible and -resistant gram-negative and gram-positive bacteria.Semantic proximity Read ↗

In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone.Semantic proximity Read ↗

In vitro antibacterial activity of DU-6859a, a new fluoroquinolone.Semantic proximity Read ↗

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agentsSemantic proximity Read ↗

In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone.Semantic proximity Read ↗

In Vitro Antibacterial Activities of JNJ-Q2, a New Broad-Spectrum FluoroquinoloneSemantic proximity Read ↗

In Vitro and In Vivo Antibacterial Activities of DC-159a, a New FluoroquinoloneSemantic proximity Read ↗

In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501). A quinolone with high activity against gram-positive bacteria.Semantic proximity Read ↗

In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.Semantic proximity Read ↗

WIN 57273, a new fluoroquinolone with enhanced in vitro activity versus gram-positive pathogens.Semantic proximity Read ↗

In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone.Semantic proximity Read ↗

Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.